Literature DB >> 29391574

Optical coherence tomography in multiple sclerosis.

Josefine Britze1, Jette Lautrup Frederiksen2.   

Abstract

To summarize recent findings regarding the utility of optical coherence tomography in multiple sclerosis. We searched PubMed for relevant articles using the keywords 'optical coherence tomography multiple sclerosis'. Additional articles were found via references in these articles. We selected articles based on relevance. Optical coherence tomography has contributed to greater insights into the pathophysiology of multiple sclerosis. Loss of retinal nerve fibre layer and ganglion cell layer thickness correlate with clinical and paraclinical parameters such as visual function, disability and magnetic resonance imaging. Some studies indicate that OCT parameters may be able to predict disability progression and visual function in MS. OCT angiography has recently emerged as a novel technique to study MS. OCT has proven very useful with regards to research, monitoring and predicting disability in multiple sclerosis. It will be interesting to see how OCT angiography will contribute to this field.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29391574      PMCID: PMC5944645          DOI: 10.1038/s41433-017-0010-2

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  44 in total

1.  A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.

Authors:  Olivier Outteryck; Bilal Majed; Sabine Defoort-Dhellemmes; Patrick Vermersch; Hélène Zéphir
Journal:  Mult Scler       Date:  2015-03-31       Impact factor: 6.312

2.  Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.

Authors:  L J Balk; M D Steenwijk; P Tewarie; M Daams; J Killestein; M P Wattjes; H Vrenken; F Barkhof; C H Polman; B M J Uitdehaag; A Petzold
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-06-27       Impact factor: 10.154

3.  Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.

Authors:  Shiv Saidha; Stephanie B Syc; Mary K Durbin; Christopher Eckstein; Jonathan D Oakley; Scott A Meyer; Amy Conger; Teresa C Frohman; Scott Newsome; John N Ratchford; Elliot M Frohman; Peter A Calabresi
Journal:  Mult Scler       Date:  2011-08-24       Impact factor: 6.312

4.  The association between retinal nerve fibre layer thickness and corpus callosum index in different clinical subtypes of multiple sclerosis.

Authors:  Vedat Cilingir; Muhammed Batur; Mehmet Deniz Bulut; Aysel Milanlioglu; Abdullah Yılgor; Abdussamet Batur; Tekin Yasar; Temel Tombul
Journal:  Neurol Sci       Date:  2017-04-10       Impact factor: 3.307

5.  Color vision impairment in multiple sclerosis points to retinal ganglion cell damage.

Authors:  E J Lampert; M Andorra; R Torres-Torres; S Ortiz-Pérez; S Llufriu; M Sepúlveda; N Sola; A Saiz; B Sánchez-Dalmau; P Villoslada; Elena H Martínez-Lapiscina
Journal:  J Neurol       Date:  2015-08-11       Impact factor: 4.849

6.  Association of retinal and macular damage with brain atrophy in multiple sclerosis.

Authors:  Jan Dörr; Klaus D Wernecke; Markus Bock; Gunnar Gaede; Jens T Wuerfel; Caspar F Pfueller; Judith Bellmann-Strobl; Alina Freing; Alexander U Brandt; Paul Friedemann
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

7.  In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosis.

Authors:  Erika Tátrai; Magdolna Simó; Anna Iljicsov; János Németh; Delia Cabrera Debuc; Gábor Márk Somfai
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

8.  Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.

Authors:  Yu Min Huang-Link; Mats Fredrikson; Hans Link
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

9.  Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.

Authors:  Julio J González-López; Gema Rebolleda; Marina Leal; Noelia Oblanca; Francisco J Muñoz-Negrete; Lucienne Costa-Frossard; José C Alvarez-Cermeño
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

10.  Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients.

Authors:  Prema Sriram; Chenyu Wang; Con Yiannikas; Raymond Garrick; Michael Barnett; John Parratt; Stuart L Graham; Hemamalini Arvind; Alexander Klistorner
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

View more
  16 in total

Review 1.  What Does Optical Coherence Tomography Offer for Evaluating Physical Disability in Patients with Multiple Sclerosis?

Authors:  Ziya Ayhan; Aylin Yaman
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

2.  Effect of Vascular Comorbidity on Visual and Disability Outcomes in a Secondary Progressive Multiple Sclerosis Clinical Trial Cohort.

Authors:  Kathleen Shangraw; Charles F Murchison; Elizabeth Silbermann; Rebecca I Spain
Journal:  Int J MS Care       Date:  2022-04-18

3.  The Eye as a Non-Invasive Window to the Microcirculation in Liver Cirrhosis: A Prospective Pilot Study.

Authors:  Fiona J Gifford; Francesca Moroni; Tariq E Farrah; Kirstie Hetherington; Tom J MacGillivray; Peter C Hayes; Neeraj Dhaun; Jonathan A Fallowfield
Journal:  J Clin Med       Date:  2020-10-17       Impact factor: 4.241

4.  Retinal Nerve Fiber Layer Thickness Correlates with Serum and Cerebrospinal Fluid Neurofilament Levels and is Associated with Current Disability in Multiple Sclerosis.

Authors:  Cihat Uzunköprü; Nur Yüceyar; Suzan Güven Yilmaz; Filiz Afrashi; Özgül Ekmekçi; Dilek Taşkiran
Journal:  Noro Psikiyatr Ars       Date:  2021-01-16       Impact factor: 1.339

5.  Determination of Referential Rates for Optical Coherence Tomography and Optical Coherence Tomography Angiography Flow Deficits in the Macular Choriocapillaris in Ophthalmologically Healthy Children.

Authors:  Viktorija Bakstytė; Liveta Šniurevičiūtė; Evelina Šimienė; Justina Skruodytė; Ingrida Janulevičienė
Journal:  Medicina (Kaunas)       Date:  2020-05-16       Impact factor: 2.430

6.  The Role of Optical Coherence Tomography in Differential Diagnosis of Multiple Sclerosis and Autoimmune Connective Tissue Diseases with CNS Involvement.

Authors:  Paula Wildner; Ewa Zydorczak; Magdalena Oset; Małgorzata Siger; Michał Wilczyński; Mariusz Stasiołek; Mariola Matysiak
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

7.  Computer-Aided Diagnosis of Multiple Sclerosis Using a Support Vector Machine and Optical Coherence Tomography Features.

Authors:  Carlo Cavaliere; Elisa Vilades; Mª C Alonso-Rodríguez; María Jesús Rodrigo; Luis Emilio Pablo; Juan Manuel Miguel; Elena López-Guillén; Eva Mª Sánchez Morla; Luciano Boquete; Elena Garcia-Martin
Journal:  Sensors (Basel)       Date:  2019-12-03       Impact factor: 3.576

Review 8.  Identification of posterior visual pathway lesions and MRI burden in people with Multiple Sclerosis.

Authors:  Tareef S Daqqaq
Journal:  Neurosciences (Riyadh)       Date:  2021-04       Impact factor: 0.906

9.  Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis.

Authors:  Sanuji Gajamange; Jim Stankovich; Gary Egan; Trevor Kilpatrick; Helmut Butzkueven; Joanne Fielding; Anneke van der Walt; Scott Kolbe
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-07-23

10.  Evaluation of Retinal Structure and Optic Nerve Function Changes in Multiple Sclerosis: Longitudinal Study with 1-Year Follow-Up.

Authors:  Riwanti Estiasari; Adisresti Diwyacitta; Muhammad Sidik; Ni Nengah Rida Ariarini; Freddy Sitorus; Saraf Shafa Marwadhani; Kartika Maharani; Darma Imran; Reza Aditya Arpandy; David Pangeran; Manfaluthy Hakim
Journal:  Neurol Res Int       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.